Dr. Scott Rocklage is a renowned expert in the healthcare management industry with over 30 years’ worth of experience in the sector. He currently serves as a managing partner at 5AM Ventures.
He joined 5AM Ventures in 2003 as a venture partner and rose to the position of managing partner within a year.
His experience and strategic leadership in the health sector led to the FDA approval of three new drug applications in the US. Learn more about Scott Rocklage: http://www.thestylemaponline.com/the-amazing-career-of-scott-rocklage-of-5am-ventures/
They include Omniscan, Teslascan, and Cubicin. Dr. Scott Rocklage has held other management positions in different healthcare organizations which include Cubist Pharmaceuticals, Nycomed Salutar, Salutar and Catalytica, and Novira.
Scott Rocklage served as the chairman and chief executive officer of Cubist Pharmaceuticals. At Nycomed Salutar he was the president and chief executive officer. He was in charge of research and development at Salutar and Catalytica.
Dr. Scott Rocklage also served as the board chairman of Relypsa and Novira. In addition to his position at 5AM Ventures, he also serves as the board chairman of Rennovia, Kinestral, Cidara, Epirus, and Pulmatrix. Read more: Scott Racklage | Bloomberg
Dr. Scott Rocklage has an extensive career background in chemistry. He holds a Bachelor’s of Science degree in Chemistry from the University of California (UC) in Berkeley and a Ph.D. in Chemistry from the Massachusetts Institute of Technology (MIT).
While pursuing his doctorate at MIT, he had the privilege of conducting his research in the laboratory of Richard R. Schrock. Richard R. Schrock received a Nobel Prize in 2005 due to his contributions in chemistry.
Dr. Scott Rocklage has amassed credit due to his numerous innovations; he has over 30 American patents he has invented or co-invented. He has also published over 100 peer-reviewed publications. Based in Boston, Massachusetts, Scott Rocklage’s outstanding track record has placed him among the most influential individuals in the healthcare management sector in the US.